Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 0.7x - 0.8x | 0.8x |
| Historical Pb Multiple | 0.5x - 1.7x | 0.6x |
| Fair Value | C$0.13 - C$0.14 | C$0.14 |
| Upside | -7.0% - 2.8% | -2.1% |
| Benchmarks | - | Full Ticker |
| Can B Corp. | - | OTCPK:CANB |
| cbdMD, Inc. | - | NYSEAM:YCBD |
| Cresco Labs Inc. | - | CNSX:CL |
| Curaleaf Holdings, Inc. | - | TSX:CURA |
| TRUBAR Inc. | - | TSXV:TRBR |
| Charlotte's Web Holdings, Inc. | - | TSX:CWEB |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| CANB | YCBD | CL | CURA | TRBR | CWEB | |||
| OTCPK:CANB | NYSEAM:YCBD | CNSX:CL | TSX:CURA | TSXV:TRBR | TSX:CWEB | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | -22.4% | 83.8% | 73.5% | -20.7% | -138.1% | 13.4% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -455.6% | -72.1% | -22.9% | -19.1% | -34.0% | -73.9% | ||
| Prior Fiscal Year | -223.2% | -111.5% | -23.2% | -17.1% | -28.2% | -37.7% | ||
| Latest Fiscal Year | -451.7% | -39.5% | -10.4% | -17.3% | -25.5% | -60.1% | ||
| Latest Twelve Months | -1282.8% | -21.2% | -6.7% | -19.2% | -29.9% | -53.1% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -15632.4% | -86.7% | -28.7% | -16.6% | -269.1% | -50.0% | ||
| Prior Fiscal Year | NM | -133.2% | -31.0% | -19.7% | -119.8% | -35.8% | ||
| Latest Twelve Months | NM | -222.4% | -10.0% | -28.6% | -334.6% | -78.0% | ||
| Next Fiscal Year | #NUM! | 619.5% | -15.1% | 1.2% | #NUM! | -63.8% | ||
| Two Fiscal Years Forward | 69.1% | 88.3% | -11.1% | -12.4% | 233.7% | -117.2% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 1.7x | 0.4x | 0.5x | 1.2x | 1.7x | 0.3x | ||
| Price / LTM EPS | -0.1x | -2.1x | -5.8x | -5.8x | -5.6x | -0.6x | ||
| Price / Book | -0.1x | 13.1x | 0.7x | 1.8x | 9.3x | 0.8x | ||
| Price / Fwd Book | -0.2x | -2.1x | 0.6x | 1.8x | 42.1x | 1.2x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | -0.1x | 1.8x | 13.1x | |||||
| Historical P/B Ratio | 0.5x | 0.6x | 1.7x | |||||
| Selected P/B Multiple | 0.7x | 0.8x | 0.8x | |||||
| (x) Book Value | 21 | 21 | 21 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CANB | YCBD | CL | CURA | TRBR | CWEB | |
| Value of Common Equity | 2 | 8 | 263 | 1,553 | 70 | 16 | |
| (/) Shares Outstanding | 90.2 | 8.9 | 355.7 | 764.4 | 107.7 | 159.1 | |
| Implied Stock Price | 0.02 | 0.88 | 0.74 | 2.03 | 0.65 | 0.10 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 0.73 | 0.73 | 0.73 | 0.73 | |
| Implied Stock Price (Trading Cur) | 0.02 | 0.88 | 1.02 | 2.80 | 0.89 | 0.14 | |
| Trading Currency | USD | USD | CAD | CAD | CAD | CAD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 0.73 | 0.73 | 0.73 | 0.73 | |